Summary

Persistence Market Research has recently released a comprehensive report on the global Anti-counterfeit Pharmaceuticals Packaging market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

- Anti-counterfeit Pharmaceuticals Packaging Market Size (2026E): US$ 131.5 Bn
- Projected Market Value (2033F): US$ 261.2 Bn
- Global Market Growth Rate (CAGR 2026-2033): 10.3%

Anti-counterfeit Pharmaceuticals Packaging Market - Report Scope

The anti-counterfeit pharmaceutical packaging market comprises solutions designed to prevent, detect, and authenticate counterfeit medicines across the global supply chain. It encompasses primary, secondary, and tertiary packaging integrated with technologies like serialization, RFID, and tamper-evident features. Applications span prescription drugs, biologics, vaccines, controlled substances, and medical devices requiring traceability and brand protection.

Market Growth Drivers

Rising prevalence of counterfeit medicines and WHO-documented supply chain threats. Regulatory mandates including DSCSA, EU FMD, and serialization requirements. Expansion of high-value biologics, vaccines, and temperature-sensitive therapies. Cross-border pharmaceutical trade and multi-tier distribution network complexity.

Market Restraints

High implementation costs ranging from $2-5 million per production line for serialization. Data interoperability challenges across supply-chain partners and regulatory systems.

Market Opportunities

Smart packaging and digital authentication via QR codes, NFC, and blockchain integration. Rapid pharmaceutical manufacturing expansion in emerging markets requiring export compliance. Integration of IoT sensors and cloud-linked traceability networks for real-time monitoring.

Key Questions Answered in the Report

- What are the major factors driving global demand for anti-counterfeit pharmaceuticals packaging?
- Which product segments and applications are fueling Anti-counterfeit Pharmaceuticals Packaging market growth?
- How is North America shaping the Anti-counterfeit Pharmaceuticals Packaging market landscape?
- Who are the leading players in the anti-counterfeit pharmaceuticals packaging market, and what strategies are they adopting?
- What are the emerging trends and long-term growth prospects for the global Anti-counterfeit Pharmaceuticals Packaging market?

Competitive Intelligence and Business Strategy

Leading players in the anti-counterfeit pharmaceuticals packaging market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Investments in advanced technologies and vertical integration help ensure consistent product quality and supply reliability. Companies are also prioritizing long-term customer relationships and geographic expansion, while emphasizing sustainability, operational efficiency, and cost optimization to gain a competitive edge.

Key Companies Profiled

- Avery Dennison Corporation
- CCL Industries Inc.
- Amcor plc
- WestRock
- Schreiner MediPharm
- SML Group
- SICPA
- 3M Company
- Antares Vision
- Holostik
- Toppan Printing
- UPM Raflatac
- DuPont
- Berry Global

Market Segmentation

By Technology
- Serialization
- RFID
- Barcodes & QR Codes
- Security Inks & Coatings
- Holograms
- Tamper-evident Seals
- Forensic Markers

By Format
- Primary Packaging
- Secondary Packaging
- Tertiary Packaging

By End-Use
- Pharmaceuticals & Healthcare
- Medical Devices & Supplies
- Controlled Substances Packaging
- Vaccines Packaging

By Region
- North America
- Europe
- East Asia
- South Asia & Oceania
- Latin America
- Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Anti-counterfeit Pharmaceuticals Packaging Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Anti-counterfeit Pharmaceuticals Packaging Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force’s Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2020 - 2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2020-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Technology
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) and Volume Analysis By Technology, 2020-2025
5.3.3. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
5.3.3.1. Serialization
5.3.3.2. RFID
5.3.3.3. Barcodes & QR Codes
5.3.3.4. Security Inks & Coatings
5.3.3.5. Holograms
5.3.3.6. Tamper-evident Seals
5.3.3.7. Forensic Markers
5.4. Market Attractiveness Analysis: Technology
5.5. Global Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Format
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) and Volume Analysis By Format, 2020-2025
5.5.3. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
5.5.3.1. Primary Packaging
5.5.3.2. Secondary Packaging
5.5.3.3. Tertiary Packaging
5.6. Market Attractiveness Analysis: Format
6. Global Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2020-2025
6.3. Current Market Size (US$ Mn) and Volume Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia & Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
7.3.1. By Country
7.3.2. By Technology
7.3.3. By Format
7.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
7.4.1. U.S.
7.4.2. Canada
7.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
7.5.1. Serialization
7.5.2. RFID
7.5.3. Barcodes & QR Codes
7.5.4. Security Inks & Coatings
7.5.5. Holograms
7.5.6. Tamper-evident Seals
7.5.7. Forensic Markers
7.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
7.6.1. Primary Packaging
7.6.2. Secondary Packaging
7.6.3. Tertiary Packaging
7.7. Market Attractiveness Analysis
8. Europe Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
8.3.1. By Country
8.3.2. By Technology
8.3.3. By Format
8.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
8.4.1. Germany
8.4.2. France
8.4.3. U.K.
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Rest of Europe
8.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
8.5.1. Serialization
8.5.2. RFID
8.5.3. Barcodes & QR Codes
8.5.4. Security Inks & Coatings
8.5.5. Holograms
8.5.6. Tamper-evident Seals
8.5.7. Forensic Markers
8.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
8.6.1. Primary Packaging
8.6.2. Secondary Packaging
8.6.3. Tertiary Packaging
8.7. Market Attractiveness Analysis
9. East Asia Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
9.3.1. By Country
9.3.2. By Technology
9.3.3. By Format
9.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
9.4.1. China
9.4.2. Japan
9.4.3. South Korea
9.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
9.5.1. Serialization
9.5.2. RFID
9.5.3. Barcodes & QR Codes
9.5.4. Security Inks & Coatings
9.5.5. Holograms
9.5.6. Tamper-evident Seals
9.5.7. Forensic Markers
9.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
9.6.1. Primary Packaging
9.6.2. Secondary Packaging
9.6.3. Tertiary Packaging
9.7. Market Attractiveness Analysis
10. South Asia & Oceania Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
10.3.1. By Country
10.3.2. By Technology
10.3.3. By Format
10.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
10.4.1. India
10.4.2. Southeast Asia
10.4.3. ANZ
10.4.4. Rest of South Asia & Oceania
10.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
10.5.1. Serialization
10.5.2. RFID
10.5.3. Barcodes & QR Codes
10.5.4. Security Inks & Coatings
10.5.5. Holograms
10.5.6. Tamper-evident Seals
10.5.7. Forensic Markers
10.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
10.6.1. Primary Packaging
10.6.2. Secondary Packaging
10.6.3. Tertiary Packaging
10.7. Market Attractiveness Analysis
11. Latin America Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
11.3.1. By Country
11.3.2. By Technology
11.3.3. By Format
11.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
11.5.1. Serialization
11.5.2. RFID
11.5.3. Barcodes & QR Codes
11.5.4. Security Inks & Coatings
11.5.5. Holograms
11.5.6. Tamper-evident Seals
11.5.7. Forensic Markers
11.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
11.6.1. Primary Packaging
11.6.2. Secondary Packaging
11.6.3. Tertiary Packaging
11.7. Market Attractiveness Analysis
12. Middle East & Africa Anti-counterfeit Pharmaceuticals Packaging Market Outlook: Historical (2020-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) and Volume Analysis By Market, 2020-2025
12.3.1. By Country
12.3.2. By Technology
12.3.3. By Format
12.4. Current Market Size (US$ Mn) and Volume Forecast By Country, 2026-2033
12.4.1. GCC
12.4.2. South Africa
12.4.3. Northern Africa
12.4.4. Rest of Middle East & Africa
12.5. Current Market Size (US$ Mn) and Volume Forecast By Technology, 2026-2033
12.5.1. Serialization
12.5.2. RFID
12.5.3. Barcodes & QR Codes
12.5.4. Security Inks & Coatings
12.5.5. Holograms
12.5.6. Tamper-evident Seals
12.5.7. Forensic Markers
12.6. Current Market Size (US$ Mn) and Volume Forecast By Format, 2026-2033
12.6.1. Primary Packaging
12.6.2. Secondary Packaging
12.6.3. Tertiary Packaging
12.7. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.2.3. Apparent Production/Service Capacity
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Avery Dennison Corporation
13.3.1.1. Overview
13.3.1.2. Segments and Products
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. CCL Industries Inc.
13.3.3. Amcor plc
13.3.4. WestRock
13.3.5. Schreiner MediPharm
13.3.6. SML Group
13.3.7. SICPA
13.3.8. 3M Company
13.3.9. Antares Vision
13.3.10. Holostik
13.3.11. Toppan Printing
13.3.12. UPM Raflatac
13.3.13. DuPont
13.3.14. Berry Global
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations